Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05418244 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Inhaled Isopropyl Alcohol for Treatment of Nausea

StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Jun 30, 2026 → Jun 30, 2027
See other at-risk trials from State University of New York at Buffalo

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Jun 30, 2026 to Jun 30, 2027 Show 4 more changesShow less
    • Eligibility criteria expanded, about 15 words
    • Secondary endpoints: details revised at 3 of 4 entries
    • Study description expanded, about 10 words
    • Site details revised
  2. Primary and study completion dates: Jun 30, 2025 to Jun 30, 2026
    • Site contact updated
    v4
  3. Primary and study completion dates: Jun 30, 2024 to Jun 30, 2025v3
  4. Primary and study completion dates: Jun 30, 2023 to Jun 30, 2024v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To determine the efficacy of inhaled isopropyl alcohol in treating nausea/vomiting among pediatric patients compared with the conventional ondansetron, or placebo treatment in a tertiary care pediatric emergency department.
Trial Details
NCT Number NCT05418244
Lead Sponsor State University of New York at Buffalo
Conditions
(from sponsor)		 Vomiting, Nausea, Children, Only
Related terms Nausea, Vomiting
Enrollment 84 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov